Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease - Test2 - elhamkhani - TriplyDB

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

http://www.wikidata.org/entity/Q26782971

about

Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells.Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields Repetitive transcranial magnetic stimulation for treatment of lactacystin-induced Parkinsonian rat model.Effect of a low-frequency pulsed electromagnetic field on expression and secretion of IL-1β and TNF-α in nucleus pulposus cells.The epigenetic component of the brain response to electromagnetic stimulation in Parkinson's Disease patients: A literature overview.Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell.

P2860

Q28078632-EC8C0C75-3168-4802-BDB0-18D1EC5BA456 Q37625554-93F8B8CE-68D9-46AF-A715-992B0914AAB6 Q39158939-9685D204-4456-431F-9507-BF31B2320761 Q41612526-21AC5F78-3CAD-47F4-B2DD-D177CDD1444B Q41921012-6DB29596-4B83-417F-A8A9-019A3974AEF7 Q48028137-77908782-6D5A-425A-A749-B9DA5AB1D737 Q55012778-06B1B725-2E33-4ADC-8A7F-0452DB8B9057

P2860

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

http://www.wikidata.org/entity/Q26782971

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@ast

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@en

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@nl

type

label

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@ast

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@en

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@nl

prefLabel

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@ast

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@en

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@nl

P1433

Q26782971-CAD5A571-2DF6-41F2-96A7-476522AC1192

P1476

Q26782971-5F6E1615-FF5C-4EF5-B20A-DA13E9416D78

P2093

Q26782971-4A485EE9-5E6A-4E92-828B-3D03869F4CB0

Q26782971-560AEEBC-1520-49A8-B07D-4CABA0C8B675

Q26782971-6580CF80-DB59-4354-8C6B-06BAD70DF410

Q26782971-971A8EF5-DB3C-485C-B6D9-35393640E5C5

Q26782971-A45E61AF-F3DC-43EF-BA1D-2710E100AB3E

Q26782971-DB8CB4CF-1E02-4495-A677-E828C8988161

P275

Q26782971-2DD15EF7-516F-4046-B82F-D16AA183DE5A

P2860

Q26782971-005B1315-0129-4519-9DFB-C94B7DBEA095

Q26782971-01D7638C-B82D-417A-89A0-E2E18337A13D

Q26782971-054D4894-E584-46EF-9746-24B9FC0F5978

Q26782971-06299170-158E-4A3E-B5FA-4F49E87EB2F4

Q26782971-063CAC1C-96E4-417E-9A1F-99609B8AEE26

Q26782971-094AC097-1D43-4C08-95EA-40856FC8D9A9

Q26782971-0C22133F-283D-452A-9CE7-C7998288CE3C

Q26782971-0DB92FDF-C537-4ED3-A560-1B84EDAF2DF1

Q26782971-0EE65BCB-77B7-4D7A-8C5B-ECF18DB0A275

Q26782971-108B03DD-66ED-4715-B3C0-11F328E8F906

P2888

Q26782971-6DD889F7-EE97-4855-8845-F0566A8B0283

P304

Q26782971-0AB905C9-0CAC-4564-81C4-E7B9A9946941

P31

Q26782971-2E9B33E8-8934-42A9-A728-7AA71E527167

Q26782971-DF8D1E3D-A07B-4AD5-B3C6-214BC6809206

P3181

Q26782971-F6844908-EC7C-4E3C-966E-E2B0ABE8117E

P356

Q26782971-DA69D1AC-F206-4ED5-B3DB-AD9D6047271F

P407

Q26782971-5B30319C-F4A6-49A8-9D81-B569657B0B73

P433

Q26782971-FF62B52A-DD22-4213-AE3C-FB05085B01C0

P478

Q26782971-EDC92B93-8E26-4459-B9BA-58A4EA9668B8

P5008

Q26782971-B202674D-BA17-4918-9525-FF9300A81A8F

P577

Q26782971-2590B771-006D-4468-BD72-F1FBE12E7F63

P5875

Q26782971-3DBFC10A-235C-4931-B2BA-64E597E1764B

P6179

Q26782971-7423B7CD-F74B-404F-AFC9-E89D6D25B175

P698

Q26782971-A06000E3-B2AF-41D9-9130-03B3C855A8CE

P921

Q26782971-6ED511FE-D2B4-4275-A724-6E92FAFBEEC8

P932

Q26782971-844DD0B3-F26F-492E-AFDB-92A98434AAA8

P3181

P356

S12993-015-0070-Z

P1433

Behavioral and Brain Functions

P1476

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease

@en

P2093

Annamaria Vallelunga

http://www.w3.org/2001/XMLSchema#string

Beniamino Palmieri

http://www.w3.org/2001/XMLSchema#string

Julio Cesar Morales-Medina

http://www.w3.org/2001/XMLSchema#string

Lucia Palmieri

http://www.w3.org/2001/XMLSchema#string

Maria Vadalà

http://www.w3.org/2001/XMLSchema#string

Tommaso Iannitti

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism

Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Efficacy of pulsed electromagnetic therapy for chronic lower back pain: a randomized, double-blind, placebo-controlled study

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996

Diagnosis and management of the patient with tremor

Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa

Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385

Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata

P2888

s12993-015-0070-z

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2961770

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12993-015-0070-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281644429

http://www.w3.org/2001/XMLSchema#string

P6179

1000146561

http://www.w3.org/2001/XMLSchema#string

P698

26347217

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4562205

http://www.w3.org/2001/XMLSchema#string